A sweeping review of dozens of clinical trials suggests that today’s most widely used GLP-1 receptor agonist drugs produce ...

Some patients taking popular GLP-1 weight loss drugs may be able to keep the weight off while taking injections less often, ...

In this week’s STATus Report, host Alex Hogan explains why weight loss pills were so much harder to develop than injectables.

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.

A recent research study found that a combination of the GLP-1 receptor agonist semaglutide and bimagrumab, an antibody that ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Having excess body weight can increase your blood pressure and affect your immune system. Learn what happens to blood ...

Adults with obesity receiving tirzepatide 15 mg achieved greater weight loss than those receiving a fixed-dose combination of cagrilintide 2.4 mg and semaglutide 2.4 mg at 84 weeks, according to ...

SEDONA, AZ, UNITED STATES, January 20, 2026 /EINPresswire.com/ — Alternative to Meds Center, a licensed residential mental health treatment facility in Sedona ...

The weight-loss medications semaglutide (Wegovy) and tirzepatide (Zepbound) have been game changers for millions of Americans who want to shed extra pounds. New data from Gallup even suggests that ...

Fat-burning workouts don’t have to end in a puddle of sweat and tears. There are all kinds of ways to lose weight with exercise. Heck, you can even walk it off. In fact, if you’re at the beginning of ...